2023年3月21日

INTEGRA生物科学很高兴宣布,它已获得Miroculus,生物技术专家致力于开发下一代测序不干涉自动化解决方案(上天)协议。这将允许INTEGRA为图书馆准备扩大其产品范围,提供学术,节省大量的时间研究和诊断实验室使用门店,最终,在这个动态领域加速发现。Miroculus总部设在旧金山,加州,成立开发创新和直观的工具,简化复杂基因组的协议,让他们可以更广泛的科学家。我们已经获得了这个有前途的创业,因为我们认识到自动化的革命性的数字微流体技术的巨大潜力和小型化基因组学协议。Miroculus自营平台提供试验的灵活性和自动化能力,使无缝工作流集成,简化实验过程,让研究人员将他们的发现转化为切实可行的解决方案,将改善人们的生活。“首席执行官乌尔斯哈特曼,INTEGRA。INTEGRA收购Miroculus为了更好地服务门店市场增长与自动化等新颖的和精确的解决方案应用程序读测序和目标浓缩协议。收购公司也保证了持续的经济增长和保障员工;两家公司优先考虑的问题。乌尔斯继续说:“Miroculus愿景和产品范围补充自己的创新的解决方案来准备样品和库,使其成为适合我公司为我们寻求建立一个竞争优势在基因组学领域。我们非常期待欢迎Miroculus团队INTEGRA家庭,毫无疑问,我们会受益于他们的专业知识和丰富的知识周围的门店。 We are confident that our combined talents will allow us to accelerate and simplify science together, and we anticipate the launch of many exciting projects in the near future, with the aim of advancing discoveries in the crucial area of genomics.” We began Miroculus with the mission to advance science and improve lives faster, and the last year has been significant for us as we’ve worked toward this goal. Most notably, we launched the Miro Canvas™ system, which is a compact and easy-to-use digital microfluidics platform that fully automates NGS sample preparation protocols and makes them accessible to scientists everywhere. We are extremely excited to now be a part of INTEGRA and to continue our shared culture of innovation for the scientific community.” Alejandro Tocigl, Co-Founder and CEO, Miroculus. Source: